We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

38 hedge funds and large institutions have $6.85M invested in Biolase, Inc. in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 38 → 38 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

52% less capital invested

Capital invested by funds: $14.4M → $6.85M (-$7.56M)

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EIM
Essex Investment Management
Massachusetts
+$395K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$40.4K
3
APP
Avantax Planning Partners
Iowa
+$30.3K
4
HF
HRT Financial
New York
+$26.5K
5
ZF
Zhang Financial
Michigan
+$22.7K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$802K
2
Millennium Management
Millennium Management
New York
-$737K
3
Renaissance Technologies
Renaissance Technologies
New York
-$720K
4
Marshall Wace
Marshall Wace
United Kingdom
-$343K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$248K
Name Holding Trade Value Shares
Change 		Change in
Stake
DA
26
DCM Advisors
New York
$6K -$40.4K -32 -82%
AI
27
Atom Investors
Texas
$6K -$16.4K -13 -68%
VF
28
Virtu Financial
New York
$5K -$99.6K -79 -94%
CFGS
29
Concourse Financial Group Securities
Alabama
$5K -$1.26K -1 -17%
AWA
30
Arete Wealth Advisors
Illinois
$5K +$6.31K +5 New
WSC
31
Wellington Shields & Co
New York
$4K – – –
TFO
32
Tarbox Family Office
California
$3K – – –
IA
33
IFP Advisors
Florida
$2K – – –
Osaic Holdings
34
Osaic Holdings
Arizona
$2K – – –
Barclays
35
Barclays
United Kingdom
$2K +$2.52K +2 New
JP Morgan Chase
36
JP Morgan Chase
New York
$2K +$2.52K +2 New
Koshinski Asset Management
37
Koshinski Asset Management
Illinois
$1.17K +$1.26K +1 New
CA
38
CoreCap Advisors
Michigan
$1K – – –
Bank of America
39
Bank of America
North Carolina
$1K +$1.26K +1 New
APA
40
American Portfolios Advisors
New York
$156 – – –
GCP
41
GSA Capital Partners
United Kingdom
– -$802K -502 Closed
Two Sigma Advisers
42
Two Sigma Advisers
New York
– -$248K -155 Closed
Two Sigma Investments
43
Two Sigma Investments
New York
– -$123K -77 Closed
Citadel Advisors
44
Citadel Advisors
Florida
– -$56K -35 Closed
CS
45
Credit Suisse
Switzerland
– -$29K -18 Closed
Jane Street
46
Jane Street
New York
– -$26K -16 Closed
CG
47
CFO4Life Group
Texas
– -$21K -13 Closed
Goldman Sachs
48
Goldman Sachs
New York
– -$15K -10 Closed
Fidelity Investments
49
Fidelity Investments
Massachusetts
– -$3.78K -3 Closed
UBS Group
50
UBS Group
Switzerland
– -$2.52K -2 Closed
1
2
3

BIOL Hedge Fund Activity: Q4 2021 in Review

38 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q4 2021, worth a combined $6.85M — down 52% from $14.4M a quarter earlier.

Fund positioning in BIOL was balanced in Q4 2021: 11 funds opened new positions, 11 closed out, 4 added to existing stakes and 11 trimmed.

The largest buyer was Essex Investment Management, adding an estimated $395K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $802K sold.

  • 38 institutional investors held Biolase, Inc. (BIOL) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $6.85M of Biolase, Inc. stock for Q4 2021, down 52% quarter-over-quarter.
  • 11 funds opened new Biolase, Inc. positions in Q4 2021 and 11 closed out, a net change of 0 holders.
  • The largest Biolase, Inc. buyer in Q4 2021 was Essex Investment Management, an estimated $395K added.
  • The largest Biolase, Inc. seller in Q4 2021 was GSA Capital Partners, an estimated $802K sold.

Based on aggregated 13F filings for Q4 2021.